It says that, between 2009 and 2011, 114 new psychoactive drugs were identified in the European Union.
The profits in psychoactive drugs, however, make it tempting to flout the law.
Among the public, scholars and within the medical profession, a backlash has developed against the widespread use of psychoactive drugs.
People need to make up their own minds about whether taking psychoactive drugs is a useful way to manage emotional problems.
Diagnostic agents, vaccines, antimicrobials, even designer psychoactive drugs all appeared on the menu.
FORBES: Hacking the President's DNA: When Synthetic Biology Meets National Security
To qualify, applicants (children included) generally must be taking psychoactive drugs.
Seeing that pharmaceutical marketing executives are evidently undeterred by the law, Dr. Angell, a senior lecturer in social medicine at Harvard Medical School and former editor in chief of The New England Journal of Medicine, advocates a prohibition on prescribing psychoactive drugs off-label.
In the past four years, AstraZeneca ( AZN), Pfizer ( PFE), Eli Lilly ( LLY), Bristol-Myers Squibb ( BMY) and Forest Labs ( FRX) have all settled federal charges of marketing psychoactive drugs off-label, at a cost running into hundreds of millions.
With different names like Annihilation, Black Mamba, Spice, Benzo Fury, Amsterdam Gold, Bombay Blue Extreme, X, Karma, Miaow miaow, Bubble, White Magic, MC, M-Cat, Bounce, and 4-MMC, these types of psychoactive, synthetic equivalents of the traditional recreational drugs are produced and marketed at the rate of more than one a week, rendering existing laws practically useless.
FORBES: Marijuana and Cocaine Are Pass�� as U.K. Reels from "Legal Drugs"
As in Britain, the New Zealand government had attempted to control the influx of new psychoactive substances by imposing emergency restrictions under existing misuse of drugs legislation.
You know, everybody's now taking psychoactive medications, anti-depressants, other mood-stabilizing drugs.
This week New Zealand publishes its Psychoactive Substances Bill, legislation which some believe will transform the international debate on drugs policy when it comes into force in August.
应用推荐